PDCD1 and neoplasm: In intracranial glioma tumor-bearing mice, the combined administration of an a-PD1 monoclonal antibody with a DC vaccine, led to long-term survival that was dependent on CD8+ T cells that infiltrated the tumor [170], while in a murine lung cancer model the combination of DC vaccination with ICIs led to 80% tumor eradication.